Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. What do you think about psilocybin’s potential to help those with alcohol addiction? Let’s dive into this week’s canna-news.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Veriheal

AUGUST 24, 2022

This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies. In May 2022, Connecticut’s governor signed a budget bill that included a provision for the implementation of psychedelic-assisted therapy treatment centers.

Legalization 111

Legalization Decriminalization Medicine Research and Development 111

Cannabis Law Report

MAY 26, 2022

Date: May 25, 2022. On May 19, 2022, a three-judge panel upheld a preliminary injunction issued by the United States District Court for the Central District of California against Boyd Street Distro, LLC, which stands accused of infringing AK Futures’ trademark on “Cake”-branded Delta-8 THC vapor products. © 2022 THOMPSON HINE LLP.

THC 52

THC Hemp DEA Consumption 52

Cannabis Law Report

JULY 27, 2022

July 27, 2022. As of July 2022, 38 states have legalized the medical use of cannabis to differing degrees. For this reason, the FDA and DEA have concluded that marijuana has no federally approved medical use in the U.S. By Raymond Lahoud. How Does Federal Law Affect Immigration? INA § 101(f)(3).

Marijuana 52

Marijuana DEA State Laws Policy 52

Cannabis Law Report

OCTOBER 15, 2019

We have noted previously that the federal Drug Enforcement Agency (DEA) recently announced that drugs that include CBD (cannabidiol) with less than 0.1% We had previously blogged on The Stoned Age: What the CBD Craze Means for Employers and Their Substance Abuse Policies , CBD is Everywhere – But Where Does the FDA Stand?

THC 40

THC CBD DEA Policy 40

Sensi Seeds

NOVEMBER 28, 2018

According to the blog post, AECOSAN was instructed by the European Food Safety Authority (EFSA) to notify industry stakeholders about the new directives. Irrespective of where the directive came from, policy on CBD has changed. CBD market at a staggering $22 billion by 2022. Rumors, Statements and Raids ??

CBD 71

CBD Seed-To-Sale Food Research and Development 71

Cannabis Law Report

AUGUST 23, 2022

By Marshall Custer on August 22, 2022. The debate surrounding delta-8 THC and the proper regulation of intoxicating hemp products has accelerated greatly over the last several months, fueled by multiple court decisions, federal policy actions, and new state laws. 21-56133, 2022 WL 1574222 (9th Cir. May 19, 2022).

Hemp 52

Hemp DEA THC Concentrates 52

Cannabis Law Report

JUNE 8, 2021

Currently Hemp Acres has 3000 acres under contract for 2021 production and anticipates contracting 10,000 acres in 2022. Tarasek works as a cannabis lawyer at Minnesota Cannabis Law, which he opened about three years ago to serve the emerging hemp industry. Adding a 21+ age restriction on delta-8 products.

Hemp 78

Hemp Seed-To-Sale Food Research and Development 78

Cannabis Law Report

JUNE 1, 2021

Remains on track to achieve positive Adjusted EBITDA during the second half of FY 2022. opportunities in Fiscal 2022.” In Q1 2022, Canopy has expanded its portfolio of THC beverages with Tweed Iced Tea beverages (available in lemon and raspberry flavors, both with 5 mg THC) now shipping. About Canopy Growth Corporation.

Data 96

Data Vaping Supply Chain Business 96

Americans for Safe Access

AUGUST 31, 2023

Their findings were sent to the Drug Enforcement Administration (DEA) who will be performing the final review for the Department of Justice (DOJ) in response to President Biden’s request in October 2022 for HHS and DOJ to look into the scheduling of cannabis.

Policy 264

Policy DEA Food Cannabis 264

Canna Law Blog

JULY 26, 2023

But, take a look: The USDA 2022 National Hemp Report , at page 1, indicates that all industrial hemp “in the open” totaled 28,314 acres. This is something that’s been talked about extensively. Bad policy and the new cannabinoids markets It always starts with policy. Not that the FDA will do much about it.

Hemp 98

Hemp DEA THC Policy 98

The Cannigma

MAY 15, 2023

Schedule III substances are subject to certain controls not applicable to all other prescription drugs, including the requirement that a medical professional with a specific license issued by the Drug Enforcement Agency (DEA) must conduct an in-person examination before prescribing it. 2 How much does ketamine therapy cost?

Therapy 106

Therapy Access Blood Pressure Treatment 106

Project CBD

AUGUST 23, 2023

But today’s “hemp” market has moved way beyond CBD, as noted by several commentators who expressed concerns about the unregulated proliferation of high-dose THC consumables and novel synthetic intoxicants thanks to loopholes in the 2018 Farm Bill, which is up for revision and renewal in the coming months. What About THCA?

Cannabinoids 143

Cannabinoids Hemp THC Safety 143

The Cannigma

FEBRUARY 16, 2022

Listen & Subscribe: In light of Black History Month, we feel it is important and relevant to talk about how minorities in the United States and around the world have been disproportionately affected by drug policy and the war on drugs. Tuning in, you’ll hear more about what these trichomes are and why they’re important.

Trichome 99

Trichome Wellness and Beauty Cannabinoids Cannabis 99

Cannabis Law Report

MAY 29, 2022

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. DEA and the Controlled Substances Act. In addition to the arduous FDA approval process, potential psychedelic therapies would also require complying with requirements from the Drug Enforcement Administration (DEA). 2] David E.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

MARCH 3, 2022

Former President Bill Clinton has apparently been hearing a lot about the therapeutic potential of CBD products for pain management lately, and, according to a now-deleted media report, said at a recent conference appearance that broad interest in the topic should spur regulators to develop standards for the cannabinoid. .

Media 52

Media CBD Events THC 52

Connor & Connor PLLC

AUGUST 15, 2024

On October 6 th , 2022, President Joe Biden asked the Secretary of the Department of Health and Human Services (HHS) and the Attorney General to review how marijuana is classified. If Congress would like to change the legal status of marijuana, they would do so before or after the DEA makes a final scheduling decision.

Marijuana 52

Marijuana DEA Policy Business 52

Cannabis Law Report

JUNE 27, 2022

The news that is attached I replicate below, and I include as well a couple of newsletters from the American Bar Association Cannabis Law & Policy Committee that I Chair. Who here can tell me what that might be about! New York Times wrote a very negative piece about dangers of teen vaping: [link]. INDUSTRY NEWS.

Seed-To-Sale 52

Seed-To-Sale Hemp Retail Treatment 52

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

As policies become more data-driven and progressive, cultivation and production technologies have continued to improve drastically over the past several years. Review our compilation of cannabis trends for 2022 to stay up to date on the latest news in the cannabis industry and ensure you are prepared for the future.

Recreational 52

Recreational Data Cannabis DEA 52

Canna Law Blog

OCTOBER 9, 2024

I was lucky enough to work with Blumenauer and his office over the years, on everything from concepts around an interstate cannabis exchange (Oregon, California, and other states have now passed bills on this), to hosting him at my old Cannabis Law and Policy course. When pressed, he would say “ this year more likely than not.”

Legislation 116

Legislation Advocacy DEA Access 116

Cannabis Law Report

FEBRUARY 28, 2022

20 February 2022. Show More According to the Drug Enforcement Administration (DEA), Schedule I drugs have “no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse.” Essay by I. Glenn Cohen & Mason Marks. war on drugs. 11 × 11.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Canna Law Blog

MARCH 7, 2023

But, there are a few important aspects of Bright Green’s proposal and 2022 EB-5 regulations that, at least in principal, make it more of a wildly risky gambit. In March of 2022, the EB-5 Reform and Integrity Act (“RIA”) was passed. Drug Enforcement Administration (“DEA”), the agency tasked with enforcing the CSA. EB-5 program.

DEA 98

DEA Research and Development Programs Cannabis 98

Canna Law Blog

JANUARY 17, 2025

I’ve started writing about it a couple of times, only to be whipsawed by filings, rulings, prominent hot takes, prominent rebuttals, and more. Specifically, in May of 2024, DOJ appointed DEA to carry its water on moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). DOJ then proposed the rule.

DEA 135

DEA Marijuana Advocacy Law 135

Veriheal

NOVEMBER 7, 2024

The Drug Enforcement Administration (DEA) announced in August that a hearing regarding the reclassification decision will take place on December 2, 2024, before an administrative law judge. Then, the DEA will review the report and draft a final ruling, factoring in all relevant information submitted during the public comment period.

DEA 97

DEA Policy Chronic Pain Marijuana 97